nodes	percent_of_prediction	percent_of_DWPC	metapath
Methadone—CYP2C8—Mometasone—systemic scleroderma	0.125	0.18	CbGbCtD
Methadone—CYP1A2—Pentoxifylline—systemic scleroderma	0.0652	0.0941	CbGbCtD
Methadone—CYP1A2—Leflunomide—systemic scleroderma	0.0622	0.0898	CbGbCtD
Methadone—ABCB1—Lisinopril—systemic scleroderma	0.057	0.0823	CbGbCtD
Methadone—CYP2C9—Leflunomide—systemic scleroderma	0.0561	0.0809	CbGbCtD
Methadone—CYP3A5—Mycophenolate mofetil—systemic scleroderma	0.0517	0.0745	CbGbCtD
Methadone—CYP2C8—Mycophenolate mofetil—systemic scleroderma	0.0497	0.0717	CbGbCtD
Methadone—ABCB1—Captopril—systemic scleroderma	0.0427	0.0616	CbGbCtD
Methadone—CYP2D6—Captopril—systemic scleroderma	0.0402	0.058	CbGbCtD
Methadone—ABCB1—Mycophenolate mofetil—systemic scleroderma	0.0336	0.0485	CbGbCtD
Methadone—CYP2C19—Prednisone—systemic scleroderma	0.0333	0.0481	CbGbCtD
Methadone—ABCB1—Prednisone—systemic scleroderma	0.0269	0.0388	CbGbCtD
Methadone—CYP3A4—Mycophenolate mofetil—systemic scleroderma	0.0201	0.0291	CbGbCtD
Methadone—CYP3A4—Prednisone—systemic scleroderma	0.0161	0.0232	CbGbCtD
Methadone—HTR3A—myenteric nerve plexus—systemic scleroderma	0.0139	0.353	CbGeAlD
Methadone—ABCB1—Methotrexate—systemic scleroderma	0.0135	0.0195	CbGbCtD
Methadone—CYP2C9—cardial valve—systemic scleroderma	0.0119	0.302	CbGeAlD
Methadone—CHRNA10—tendon—systemic scleroderma	0.00217	0.0549	CbGeAlD
Methadone—CYP2C18—digestive system—systemic scleroderma	0.00157	0.0397	CbGeAlD
Methadone—CYP19A1—connective tissue—systemic scleroderma	0.00113	0.0285	CbGeAlD
Methadone—HTR3A—digestive system—systemic scleroderma	0.00106	0.0267	CbGeAlD
Methadone—HTR3A—lung—systemic scleroderma	0.000882	0.0223	CbGeAlD
Methadone—ABCB1—blood vessel—systemic scleroderma	0.000754	0.0191	CbGeAlD
Methadone—CYP2C19—digestive system—systemic scleroderma	0.000667	0.0169	CbGeAlD
Methadone—CYP2B6—skin of body—systemic scleroderma	0.000653	0.0165	CbGeAlD
Methadone—CYP1A2—digestive system—systemic scleroderma	0.000545	0.0138	CbGeAlD
Methadone—Palpitations—Mycophenolic acid—systemic scleroderma	0.000526	0.00197	CcSEcCtD
Methadone—CYP3A5—digestive system—systemic scleroderma	0.000525	0.0133	CbGeAlD
Methadone—Loss of consciousness—Mycophenolic acid—systemic scleroderma	0.000523	0.00196	CcSEcCtD
Methadone—CYP2B6—digestive system—systemic scleroderma	0.000522	0.0132	CbGeAlD
Methadone—Visual impairment—Mycophenolate mofetil—systemic scleroderma	0.00052	0.00194	CcSEcCtD
Methadone—Dry mouth—Leflunomide—systemic scleroderma	0.000519	0.00194	CcSEcCtD
Methadone—Vomiting—Pentoxifylline—systemic scleroderma	0.000518	0.00194	CcSEcCtD
Methadone—CYP2C9—digestive system—systemic scleroderma	0.000517	0.0131	CbGeAlD
Methadone—Convulsion—Mycophenolic acid—systemic scleroderma	0.000515	0.00193	CcSEcCtD
Methadone—Muscle spasms—Lisinopril—systemic scleroderma	0.000515	0.00193	CcSEcCtD
Methadone—Rash—Pentoxifylline—systemic scleroderma	0.000514	0.00192	CcSEcCtD
Methadone—Dermatitis—Pentoxifylline—systemic scleroderma	0.000513	0.00192	CcSEcCtD
Methadone—Headache—Pentoxifylline—systemic scleroderma	0.00051	0.00191	CcSEcCtD
Methadone—Anaphylactic shock—Leflunomide—systemic scleroderma	0.000509	0.0019	CcSEcCtD
Methadone—Feeling abnormal—Captopril—systemic scleroderma	0.000509	0.0019	CcSEcCtD
Methadone—Gastrointestinal pain—Captopril—systemic scleroderma	0.000505	0.00189	CcSEcCtD
Methadone—Anxiety—Mycophenolic acid—systemic scleroderma	0.000505	0.00189	CcSEcCtD
Methadone—Asthenia—Mometasone—systemic scleroderma	0.000504	0.00189	CcSEcCtD
Methadone—Irritability—Prednisone—systemic scleroderma	0.000504	0.00189	CcSEcCtD
Methadone—Hypotension—Azathioprine—systemic scleroderma	0.000503	0.00188	CcSEcCtD
Methadone—Cardiac arrest—Prednisone—systemic scleroderma	0.000502	0.00188	CcSEcCtD
Methadone—Tremor—Lisinopril—systemic scleroderma	0.000502	0.00188	CcSEcCtD
Methadone—Thrombocytopenia—Leflunomide—systemic scleroderma	0.000498	0.00186	CcSEcCtD
Methadone—Pruritus—Mometasone—systemic scleroderma	0.000497	0.00186	CcSEcCtD
Methadone—Tachycardia—Leflunomide—systemic scleroderma	0.000497	0.00186	CcSEcCtD
Methadone—Dry mouth—Mycophenolic acid—systemic scleroderma	0.000495	0.00185	CcSEcCtD
Methadone—Hyperhidrosis—Leflunomide—systemic scleroderma	0.000492	0.00184	CcSEcCtD
Methadone—Confusional state—Mycophenolic acid—systemic scleroderma	0.000489	0.00183	CcSEcCtD
Methadone—Body temperature increased—Captopril—systemic scleroderma	0.000488	0.00183	CcSEcCtD
Methadone—Abdominal pain—Captopril—systemic scleroderma	0.000488	0.00183	CcSEcCtD
Methadone—Oedema—Mycophenolic acid—systemic scleroderma	0.000485	0.00182	CcSEcCtD
Methadone—Anorexia—Leflunomide—systemic scleroderma	0.000485	0.00181	CcSEcCtD
Methadone—Nausea—Pentoxifylline—systemic scleroderma	0.000484	0.00181	CcSEcCtD
Methadone—Chills—Mycophenolate mofetil—systemic scleroderma	0.000484	0.00181	CcSEcCtD
Methadone—Arrhythmia—Mycophenolate mofetil—systemic scleroderma	0.000482	0.0018	CcSEcCtD
Methadone—Vertigo—Lisinopril—systemic scleroderma	0.000481	0.0018	CcSEcCtD
Methadone—Diarrhoea—Mometasone—systemic scleroderma	0.000481	0.0018	CcSEcCtD
Methadone—Hypokalaemia—Prednisone—systemic scleroderma	0.000481	0.0018	CcSEcCtD
Methadone—Syncope—Lisinopril—systemic scleroderma	0.00048	0.0018	CcSEcCtD
Methadone—Shock—Mycophenolic acid—systemic scleroderma	0.000477	0.00179	CcSEcCtD
Methadone—Hypotension—Leflunomide—systemic scleroderma	0.000475	0.00178	CcSEcCtD
Methadone—Thrombocytopenia—Mycophenolic acid—systemic scleroderma	0.000475	0.00178	CcSEcCtD
Methadone—Tachycardia—Mycophenolic acid—systemic scleroderma	0.000474	0.00177	CcSEcCtD
Methadone—Palpitations—Lisinopril—systemic scleroderma	0.000473	0.00177	CcSEcCtD
Methadone—Loss of consciousness—Lisinopril—systemic scleroderma	0.000471	0.00176	CcSEcCtD
Methadone—Hyperhidrosis—Mycophenolic acid—systemic scleroderma	0.000469	0.00175	CcSEcCtD
Methadone—Visual disturbance—Methotrexate—systemic scleroderma	0.000466	0.00174	CcSEcCtD
Methadone—Anorexia—Mycophenolic acid—systemic scleroderma	0.000463	0.00173	CcSEcCtD
Methadone—Insomnia—Leflunomide—systemic scleroderma	0.00046	0.00172	CcSEcCtD
Methadone—CYP1A2—lung—systemic scleroderma	0.000455	0.0115	CbGeAlD
Methadone—Anxiety—Lisinopril—systemic scleroderma	0.000454	0.0017	CcSEcCtD
Methadone—Hypotension—Mycophenolic acid—systemic scleroderma	0.000454	0.0017	CcSEcCtD
Methadone—Muscle spasms—Mycophenolate mofetil—systemic scleroderma	0.000451	0.00169	CcSEcCtD
Methadone—Vomiting—Mometasone—systemic scleroderma	0.000447	0.00167	CcSEcCtD
Methadone—Dry mouth—Lisinopril—systemic scleroderma	0.000446	0.00167	CcSEcCtD
Methadone—Sweating increased—Prednisone—systemic scleroderma	0.000445	0.00166	CcSEcCtD
Methadone—Feeling abnormal—Azathioprine—systemic scleroderma	0.000444	0.00166	CcSEcCtD
Methadone—Rash—Mometasone—systemic scleroderma	0.000443	0.00166	CcSEcCtD
Methadone—Asthenia—Captopril—systemic scleroderma	0.000443	0.00166	CcSEcCtD
Methadone—Dermatitis—Mometasone—systemic scleroderma	0.000443	0.00166	CcSEcCtD
Methadone—Decreased appetite—Leflunomide—systemic scleroderma	0.000442	0.00165	CcSEcCtD
Methadone—Confusional state—Lisinopril—systemic scleroderma	0.000441	0.00165	CcSEcCtD
Methadone—Gastrointestinal pain—Azathioprine—systemic scleroderma	0.000441	0.00165	CcSEcCtD
Methadone—Headache—Mometasone—systemic scleroderma	0.00044	0.00165	CcSEcCtD
Methadone—Tremor—Mycophenolate mofetil—systemic scleroderma	0.00044	0.00164	CcSEcCtD
Methadone—Insomnia—Mycophenolic acid—systemic scleroderma	0.000439	0.00164	CcSEcCtD
Methadone—CYP3A5—lung—systemic scleroderma	0.000439	0.0111	CbGeAlD
Methadone—Anaphylactic shock—Lisinopril—systemic scleroderma	0.000437	0.00164	CcSEcCtD
Methadone—Oedema—Lisinopril—systemic scleroderma	0.000437	0.00164	CcSEcCtD
Methadone—Pruritus—Captopril—systemic scleroderma	0.000437	0.00163	CcSEcCtD
Methadone—CYP2B6—lung—systemic scleroderma	0.000436	0.011	CbGeAlD
Methadone—Constipation—Leflunomide—systemic scleroderma	0.000435	0.00163	CcSEcCtD
Methadone—Pain—Leflunomide—systemic scleroderma	0.000435	0.00163	CcSEcCtD
Methadone—Somnolence—Mycophenolic acid—systemic scleroderma	0.000431	0.00161	CcSEcCtD
Methadone—Agitation—Mycophenolate mofetil—systemic scleroderma	0.000431	0.00161	CcSEcCtD
Methadone—Shock—Lisinopril—systemic scleroderma	0.00043	0.00161	CcSEcCtD
Methadone—Thrombocytopenia—Lisinopril—systemic scleroderma	0.000428	0.0016	CcSEcCtD
Methadone—Tachycardia—Lisinopril—systemic scleroderma	0.000427	0.0016	CcSEcCtD
Methadone—Body temperature increased—Azathioprine—systemic scleroderma	0.000426	0.00159	CcSEcCtD
Methadone—Abdominal pain—Azathioprine—systemic scleroderma	0.000426	0.00159	CcSEcCtD
Methadone—Hyperhidrosis—Lisinopril—systemic scleroderma	0.000423	0.00158	CcSEcCtD
Methadone—Diarrhoea—Captopril—systemic scleroderma	0.000422	0.00158	CcSEcCtD
Methadone—Decreased appetite—Mycophenolic acid—systemic scleroderma	0.000422	0.00158	CcSEcCtD
Methadone—Vertigo—Mycophenolate mofetil—systemic scleroderma	0.000422	0.00158	CcSEcCtD
Methadone—Irritability—Methotrexate—systemic scleroderma	0.000421	0.00158	CcSEcCtD
Methadone—Syncope—Mycophenolate mofetil—systemic scleroderma	0.000421	0.00157	CcSEcCtD
Methadone—Feeling abnormal—Leflunomide—systemic scleroderma	0.000419	0.00157	CcSEcCtD
Methadone—Nausea—Mometasone—systemic scleroderma	0.000417	0.00156	CcSEcCtD
Methadone—Anorexia—Lisinopril—systemic scleroderma	0.000417	0.00156	CcSEcCtD
Methadone—Gastrointestinal pain—Leflunomide—systemic scleroderma	0.000416	0.00156	CcSEcCtD
Methadone—Weight increased—Prednisone—systemic scleroderma	0.000415	0.00155	CcSEcCtD
Methadone—Pain—Mycophenolic acid—systemic scleroderma	0.000415	0.00155	CcSEcCtD
Methadone—Constipation—Mycophenolic acid—systemic scleroderma	0.000415	0.00155	CcSEcCtD
Methadone—Palpitations—Mycophenolate mofetil—systemic scleroderma	0.000415	0.00155	CcSEcCtD
Methadone—Weight decreased—Prednisone—systemic scleroderma	0.000413	0.00155	CcSEcCtD
Methadone—Loss of consciousness—Mycophenolate mofetil—systemic scleroderma	0.000412	0.00154	CcSEcCtD
Methadone—Hypotension—Lisinopril—systemic scleroderma	0.000408	0.00153	CcSEcCtD
Methadone—Dizziness—Captopril—systemic scleroderma	0.000408	0.00153	CcSEcCtD
Methadone—Convulsion—Mycophenolate mofetil—systemic scleroderma	0.000407	0.00152	CcSEcCtD
Methadone—Urticaria—Leflunomide—systemic scleroderma	0.000404	0.00151	CcSEcCtD
Methadone—Body temperature increased—Leflunomide—systemic scleroderma	0.000402	0.0015	CcSEcCtD
Methadone—Abdominal pain—Leflunomide—systemic scleroderma	0.000402	0.0015	CcSEcCtD
Methadone—Feeling abnormal—Mycophenolic acid—systemic scleroderma	0.0004	0.0015	CcSEcCtD
Methadone—Anxiety—Mycophenolate mofetil—systemic scleroderma	0.000398	0.00149	CcSEcCtD
Methadone—Hypersensitivity—Azathioprine—systemic scleroderma	0.000397	0.00148	CcSEcCtD
Methadone—Gastrointestinal pain—Mycophenolic acid—systemic scleroderma	0.000397	0.00148	CcSEcCtD
Methadone—Insomnia—Lisinopril—systemic scleroderma	0.000395	0.00148	CcSEcCtD
Methadone—CYP3A4—digestive system—systemic scleroderma	0.000394	0.00998	CbGeAlD
Methadone—Vomiting—Captopril—systemic scleroderma	0.000392	0.00147	CcSEcCtD
Methadone—Dry mouth—Mycophenolate mofetil—systemic scleroderma	0.000391	0.00146	CcSEcCtD
Methadone—Rash—Captopril—systemic scleroderma	0.000389	0.00146	CcSEcCtD
Methadone—Dermatitis—Captopril—systemic scleroderma	0.000389	0.00145	CcSEcCtD
Methadone—Somnolence—Lisinopril—systemic scleroderma	0.000389	0.00145	CcSEcCtD
Methadone—CYP2D6—digestive system—systemic scleroderma	0.000388	0.00982	CbGeAlD
Methadone—Headache—Captopril—systemic scleroderma	0.000387	0.00145	CcSEcCtD
Methadone—Confusional state—Mycophenolate mofetil—systemic scleroderma	0.000386	0.00144	CcSEcCtD
Methadone—Body temperature increased—Mycophenolic acid—systemic scleroderma	0.000384	0.00144	CcSEcCtD
Methadone—Abdominal pain—Mycophenolic acid—systemic scleroderma	0.000384	0.00144	CcSEcCtD
Methadone—Anaphylactic shock—Mycophenolate mofetil—systemic scleroderma	0.000383	0.00143	CcSEcCtD
Methadone—Oedema—Mycophenolate mofetil—systemic scleroderma	0.000383	0.00143	CcSEcCtD
Methadone—Decreased appetite—Lisinopril—systemic scleroderma	0.00038	0.00142	CcSEcCtD
Methadone—Shock—Mycophenolate mofetil—systemic scleroderma	0.000377	0.00141	CcSEcCtD
Methadone—Thrombocytopenia—Mycophenolate mofetil—systemic scleroderma	0.000375	0.0014	CcSEcCtD
Methadone—Hypersensitivity—Leflunomide—systemic scleroderma	0.000375	0.0014	CcSEcCtD
Methadone—Constipation—Lisinopril—systemic scleroderma	0.000374	0.0014	CcSEcCtD
Methadone—Pain—Lisinopril—systemic scleroderma	0.000374	0.0014	CcSEcCtD
Methadone—Tachycardia—Mycophenolate mofetil—systemic scleroderma	0.000374	0.0014	CcSEcCtD
Methadone—Bradycardia—Prednisone—systemic scleroderma	0.000372	0.00139	CcSEcCtD
Methadone—Hyperhidrosis—Mycophenolate mofetil—systemic scleroderma	0.00037	0.00139	CcSEcCtD
Methadone—Diarrhoea—Azathioprine—systemic scleroderma	0.000369	0.00138	CcSEcCtD
Methadone—Nausea—Captopril—systemic scleroderma	0.000367	0.00137	CcSEcCtD
Methadone—Anorexia—Mycophenolate mofetil—systemic scleroderma	0.000365	0.00137	CcSEcCtD
Methadone—Asthenia—Leflunomide—systemic scleroderma	0.000365	0.00137	CcSEcCtD
Methadone—Hallucination—Prednisone—systemic scleroderma	0.000364	0.00136	CcSEcCtD
Methadone—Feeling abnormal—Lisinopril—systemic scleroderma	0.00036	0.00135	CcSEcCtD
Methadone—Pruritus—Leflunomide—systemic scleroderma	0.00036	0.00135	CcSEcCtD
Methadone—Hypotension—Mycophenolate mofetil—systemic scleroderma	0.000358	0.00134	CcSEcCtD
Methadone—Gastrointestinal pain—Lisinopril—systemic scleroderma	0.000357	0.00134	CcSEcCtD
Methadone—Dizziness—Azathioprine—systemic scleroderma	0.000356	0.00133	CcSEcCtD
Methadone—Asthenia—Mycophenolic acid—systemic scleroderma	0.000348	0.0013	CcSEcCtD
Methadone—Diarrhoea—Leflunomide—systemic scleroderma	0.000348	0.0013	CcSEcCtD
Methadone—Urticaria—Lisinopril—systemic scleroderma	0.000347	0.0013	CcSEcCtD
Methadone—Insomnia—Mycophenolate mofetil—systemic scleroderma	0.000346	0.0013	CcSEcCtD
Methadone—Abdominal pain—Lisinopril—systemic scleroderma	0.000346	0.00129	CcSEcCtD
Methadone—Body temperature increased—Lisinopril—systemic scleroderma	0.000346	0.00129	CcSEcCtD
Methadone—Pruritus—Mycophenolic acid—systemic scleroderma	0.000343	0.00128	CcSEcCtD
Methadone—Vomiting—Azathioprine—systemic scleroderma	0.000343	0.00128	CcSEcCtD
Methadone—Somnolence—Mycophenolate mofetil—systemic scleroderma	0.00034	0.00127	CcSEcCtD
Methadone—Drowsiness—Methotrexate—systemic scleroderma	0.00034	0.00127	CcSEcCtD
Methadone—Rash—Azathioprine—systemic scleroderma	0.00034	0.00127	CcSEcCtD
Methadone—Dermatitis—Azathioprine—systemic scleroderma	0.000339	0.00127	CcSEcCtD
Methadone—Flushing—Prednisone—systemic scleroderma	0.000339	0.00127	CcSEcCtD
Methadone—Headache—Azathioprine—systemic scleroderma	0.000337	0.00126	CcSEcCtD
Methadone—Dizziness—Leflunomide—systemic scleroderma	0.000336	0.00126	CcSEcCtD
Methadone—Decreased appetite—Mycophenolate mofetil—systemic scleroderma	0.000333	0.00125	CcSEcCtD
Methadone—Diarrhoea—Mycophenolic acid—systemic scleroderma	0.000332	0.00124	CcSEcCtD
Methadone—Pain—Mycophenolate mofetil—systemic scleroderma	0.000328	0.00123	CcSEcCtD
Methadone—Constipation—Mycophenolate mofetil—systemic scleroderma	0.000328	0.00123	CcSEcCtD
Methadone—Arrhythmia—Prednisone—systemic scleroderma	0.000326	0.00122	CcSEcCtD
Methadone—Sweating—Methotrexate—systemic scleroderma	0.000326	0.00122	CcSEcCtD
Methadone—Vomiting—Leflunomide—systemic scleroderma	0.000323	0.00121	CcSEcCtD
Methadone—Hypersensitivity—Lisinopril—systemic scleroderma	0.000322	0.0012	CcSEcCtD
Methadone—Dizziness—Mycophenolic acid—systemic scleroderma	0.000321	0.0012	CcSEcCtD
Methadone—Rash—Leflunomide—systemic scleroderma	0.000321	0.0012	CcSEcCtD
Methadone—Dermatitis—Leflunomide—systemic scleroderma	0.00032	0.0012	CcSEcCtD
Methadone—Nausea—Azathioprine—systemic scleroderma	0.00032	0.0012	CcSEcCtD
Methadone—Headache—Leflunomide—systemic scleroderma	0.000319	0.00119	CcSEcCtD
Methadone—Erythema—Prednisone—systemic scleroderma	0.000318	0.00119	CcSEcCtD
Methadone—Feeling abnormal—Mycophenolate mofetil—systemic scleroderma	0.000316	0.00118	CcSEcCtD
Methadone—Asthenia—Lisinopril—systemic scleroderma	0.000314	0.00117	CcSEcCtD
Methadone—Gastrointestinal pain—Mycophenolate mofetil—systemic scleroderma	0.000313	0.00117	CcSEcCtD
Methadone—Pruritus—Lisinopril—systemic scleroderma	0.000309	0.00116	CcSEcCtD
Methadone—Vomiting—Mycophenolic acid—systemic scleroderma	0.000309	0.00115	CcSEcCtD
Methadone—Rash—Mycophenolic acid—systemic scleroderma	0.000306	0.00114	CcSEcCtD
Methadone—Dermatitis—Mycophenolic acid—systemic scleroderma	0.000306	0.00114	CcSEcCtD
Methadone—Urticaria—Mycophenolate mofetil—systemic scleroderma	0.000304	0.00114	CcSEcCtD
Methadone—Headache—Mycophenolic acid—systemic scleroderma	0.000304	0.00114	CcSEcCtD
Methadone—Abdominal pain—Mycophenolate mofetil—systemic scleroderma	0.000303	0.00113	CcSEcCtD
Methadone—Body temperature increased—Mycophenolate mofetil—systemic scleroderma	0.000303	0.00113	CcSEcCtD
Methadone—Nausea—Leflunomide—systemic scleroderma	0.000302	0.00113	CcSEcCtD
Methadone—Diarrhoea—Lisinopril—systemic scleroderma	0.000299	0.00112	CcSEcCtD
Methadone—Visual impairment—Methotrexate—systemic scleroderma	0.000294	0.0011	CcSEcCtD
Methadone—Agitation—Prednisone—systemic scleroderma	0.000292	0.00109	CcSEcCtD
Methadone—Dizziness—Lisinopril—systemic scleroderma	0.000289	0.00108	CcSEcCtD
Methadone—Nausea—Mycophenolic acid—systemic scleroderma	0.000288	0.00108	CcSEcCtD
Methadone—Vertigo—Prednisone—systemic scleroderma	0.000286	0.00107	CcSEcCtD
Methadone—Syncope—Prednisone—systemic scleroderma	0.000285	0.00107	CcSEcCtD
Methadone—Hypersensitivity—Mycophenolate mofetil—systemic scleroderma	0.000282	0.00106	CcSEcCtD
Methadone—Loss of consciousness—Prednisone—systemic scleroderma	0.00028	0.00105	CcSEcCtD
Methadone—ABCB1—digestive system—systemic scleroderma	0.000279	0.00707	CbGeAlD
Methadone—Vomiting—Lisinopril—systemic scleroderma	0.000278	0.00104	CcSEcCtD
Methadone—Rash—Lisinopril—systemic scleroderma	0.000276	0.00103	CcSEcCtD
Methadone—Convulsion—Prednisone—systemic scleroderma	0.000276	0.00103	CcSEcCtD
Methadone—Dermatitis—Lisinopril—systemic scleroderma	0.000275	0.00103	CcSEcCtD
Methadone—Asthenia—Mycophenolate mofetil—systemic scleroderma	0.000275	0.00103	CcSEcCtD
Methadone—Chills—Methotrexate—systemic scleroderma	0.000274	0.00103	CcSEcCtD
Methadone—Headache—Lisinopril—systemic scleroderma	0.000274	0.00102	CcSEcCtD
Methadone—Pruritus—Mycophenolate mofetil—systemic scleroderma	0.000271	0.00101	CcSEcCtD
Methadone—Anxiety—Prednisone—systemic scleroderma	0.00027	0.00101	CcSEcCtD
Methadone—Erythema—Methotrexate—systemic scleroderma	0.000266	0.000994	CcSEcCtD
Methadone—Diarrhoea—Mycophenolate mofetil—systemic scleroderma	0.000262	0.00098	CcSEcCtD
Methadone—Nausea—Lisinopril—systemic scleroderma	0.00026	0.000971	CcSEcCtD
Methadone—Oedema—Prednisone—systemic scleroderma	0.00026	0.000971	CcSEcCtD
Methadone—Anaphylactic shock—Prednisone—systemic scleroderma	0.00026	0.000971	CcSEcCtD
Methadone—Shock—Prednisone—systemic scleroderma	0.000255	0.000955	CcSEcCtD
Methadone—Tachycardia—Prednisone—systemic scleroderma	0.000253	0.000948	CcSEcCtD
Methadone—Dizziness—Mycophenolate mofetil—systemic scleroderma	0.000253	0.000947	CcSEcCtD
Methadone—Hyperhidrosis—Prednisone—systemic scleroderma	0.000251	0.000939	CcSEcCtD
Methadone—Anorexia—Prednisone—systemic scleroderma	0.000247	0.000926	CcSEcCtD
Methadone—Vomiting—Mycophenolate mofetil—systemic scleroderma	0.000244	0.000911	CcSEcCtD
Methadone—Rash—Mycophenolate mofetil—systemic scleroderma	0.000241	0.000903	CcSEcCtD
Methadone—Dermatitis—Mycophenolate mofetil—systemic scleroderma	0.000241	0.000902	CcSEcCtD
Methadone—Headache—Mycophenolate mofetil—systemic scleroderma	0.00024	0.000898	CcSEcCtD
Methadone—Vertigo—Methotrexate—systemic scleroderma	0.000239	0.000893	CcSEcCtD
Methadone—Insomnia—Prednisone—systemic scleroderma	0.000235	0.000878	CcSEcCtD
Methadone—ABCB1—lung—systemic scleroderma	0.000233	0.0059	CbGeAlD
Methadone—Convulsion—Methotrexate—systemic scleroderma	0.00023	0.000862	CcSEcCtD
Methadone—Nausea—Mycophenolate mofetil—systemic scleroderma	0.000228	0.000851	CcSEcCtD
Methadone—Decreased appetite—Prednisone—systemic scleroderma	0.000226	0.000844	CcSEcCtD
Methadone—Constipation—Prednisone—systemic scleroderma	0.000222	0.00083	CcSEcCtD
Methadone—Confusional state—Methotrexate—systemic scleroderma	0.000219	0.000818	CcSEcCtD
Methadone—Anaphylactic shock—Methotrexate—systemic scleroderma	0.000217	0.000812	CcSEcCtD
Methadone—Feeling abnormal—Prednisone—systemic scleroderma	0.000214	0.0008	CcSEcCtD
Methadone—Thrombocytopenia—Methotrexate—systemic scleroderma	0.000212	0.000795	CcSEcCtD
Methadone—Gastrointestinal pain—Prednisone—systemic scleroderma	0.000212	0.000794	CcSEcCtD
Methadone—Hyperhidrosis—Methotrexate—systemic scleroderma	0.00021	0.000785	CcSEcCtD
Methadone—Anorexia—Methotrexate—systemic scleroderma	0.000207	0.000774	CcSEcCtD
Methadone—Urticaria—Prednisone—systemic scleroderma	0.000206	0.000771	CcSEcCtD
Methadone—Abdominal pain—Prednisone—systemic scleroderma	0.000205	0.000768	CcSEcCtD
Methadone—Body temperature increased—Prednisone—systemic scleroderma	0.000205	0.000768	CcSEcCtD
Methadone—Hypotension—Methotrexate—systemic scleroderma	0.000203	0.000758	CcSEcCtD
Methadone—Insomnia—Methotrexate—systemic scleroderma	0.000196	0.000734	CcSEcCtD
Methadone—Somnolence—Methotrexate—systemic scleroderma	0.000193	0.000722	CcSEcCtD
Methadone—Hypersensitivity—Prednisone—systemic scleroderma	0.000191	0.000715	CcSEcCtD
Methadone—Decreased appetite—Methotrexate—systemic scleroderma	0.000189	0.000706	CcSEcCtD
Methadone—Asthenia—Prednisone—systemic scleroderma	0.000186	0.000697	CcSEcCtD
Methadone—Pain—Methotrexate—systemic scleroderma	0.000186	0.000694	CcSEcCtD
Methadone—Pruritus—Prednisone—systemic scleroderma	0.000184	0.000687	CcSEcCtD
Methadone—Feeling abnormal—Methotrexate—systemic scleroderma	0.000179	0.000669	CcSEcCtD
Methadone—Diarrhoea—Prednisone—systemic scleroderma	0.000178	0.000664	CcSEcCtD
Methadone—Gastrointestinal pain—Methotrexate—systemic scleroderma	0.000177	0.000664	CcSEcCtD
Methadone—Urticaria—Methotrexate—systemic scleroderma	0.000172	0.000645	CcSEcCtD
Methadone—Dizziness—Prednisone—systemic scleroderma	0.000172	0.000642	CcSEcCtD
Methadone—Abdominal pain—Methotrexate—systemic scleroderma	0.000172	0.000642	CcSEcCtD
Methadone—Body temperature increased—Methotrexate—systemic scleroderma	0.000172	0.000642	CcSEcCtD
Methadone—Vomiting—Prednisone—systemic scleroderma	0.000165	0.000617	CcSEcCtD
Methadone—Rash—Prednisone—systemic scleroderma	0.000164	0.000612	CcSEcCtD
Methadone—Dermatitis—Prednisone—systemic scleroderma	0.000164	0.000612	CcSEcCtD
Methadone—Headache—Prednisone—systemic scleroderma	0.000163	0.000608	CcSEcCtD
Methadone—Hypersensitivity—Methotrexate—systemic scleroderma	0.00016	0.000598	CcSEcCtD
Methadone—Asthenia—Methotrexate—systemic scleroderma	0.000156	0.000582	CcSEcCtD
Methadone—Nausea—Prednisone—systemic scleroderma	0.000154	0.000577	CcSEcCtD
Methadone—Pruritus—Methotrexate—systemic scleroderma	0.000154	0.000574	CcSEcCtD
Methadone—Diarrhoea—Methotrexate—systemic scleroderma	0.000148	0.000555	CcSEcCtD
Methadone—Dizziness—Methotrexate—systemic scleroderma	0.000143	0.000537	CcSEcCtD
Methadone—Vomiting—Methotrexate—systemic scleroderma	0.000138	0.000516	CcSEcCtD
Methadone—Rash—Methotrexate—systemic scleroderma	0.000137	0.000512	CcSEcCtD
Methadone—Dermatitis—Methotrexate—systemic scleroderma	0.000137	0.000511	CcSEcCtD
Methadone—Headache—Methotrexate—systemic scleroderma	0.000136	0.000508	CcSEcCtD
Methadone—Nausea—Methotrexate—systemic scleroderma	0.000129	0.000482	CcSEcCtD
